← FDA Drug Approvals (Drugs@FDA)
JANUMET XR
NDA · New Drug Application · Sponsor: MSD SUB MERCK · Approved 2012-02-02
Drug application
- FDA Application #
NDA202270- Application type
- New Drug Application
- Brand name
- JANUMET XR
- Generic name
- SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
- Active ingredients
- METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- MSD SUB MERCK
- Manufacturer
- Merck Sharp & Dohme LLC
- First approval
- 2012-02-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown